Improving cancer clinical trial participation in the Deep South
NCTN Deep South Research Consortium
This study is working to make it easier for cancer patients, especially those from minority backgrounds, to join clinical trials at the University of Alabama at Birmingham, so we can improve treatment options for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11251864 on NIH RePORTER |
What this research studies
This research focuses on enhancing the involvement of the University of Alabama at Birmingham's O’Neal Comprehensive Cancer Center in the National Clinical Trials Network. It aims to optimize the process for enrolling eligible cancer patients and those at risk for cancer into clinical trials. The project also emphasizes increasing participation from minority populations to ensure diverse representation in cancer research. By developing future scientific leaders and refining trial processes, the research seeks to improve cancer treatment options for patients.
Who could benefit from this research
Good fit: Ideal candidates for participation include cancer patients and individuals at risk for cancer, particularly from minority backgrounds.
Not a fit: Patients who are not diagnosed with cancer or do not have a family history of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to innovative cancer treatments for patients in the Deep South.
How similar studies have performed: Previous research has shown success in increasing clinical trial participation through targeted outreach and community engagement strategies.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Leath, Charles a. — University of Alabama at Birmingham
- Study coordinator: Leath, Charles a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.